Purpureaside C

CAS No. 108648-07-3

Purpureaside C( —— )

Catalog No. M29599 CAS No. 108648-07-3

Purpureaside C is a phenolic glycoside with significant proinflammatory, immunomodulating and antimicrobial effects.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 493 In Stock
5MG 448 In Stock
10MG 622 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Purpureaside C
  • Note
    Research use only, not for human use.
  • Brief Description
    Purpureaside C is a phenolic glycoside with significant proinflammatory, immunomodulating and antimicrobial effects.
  • Description
    Purpureaside C is a phenolic glycoside with significant proinflammatory, immunomodulating and antimicrobial effects.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    108648-07-3
  • Formula Weight
    786.733
  • Molecular Formula
    C35H46O20
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 125 mg/mL (158.89 mM)
  • SMILES
    [H][C@@]1(O[C@@H]2C(O)C(OCCc3ccc(O)c(O)c3)O[C@H](CO[C@@H]3O[C@H](CO)C(O)C(O)C3O)C2OC(=O)\C=C\c2ccc(O)c(O)c2)OC(C)[C@H](O)[C@@H](O)[C@H]1O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Diisopropyl xanthoge...

    Diisopropyl xanthogen disulfide can be used to synthesize a proligand for metal complexes related to the molybdenum cofactor.

  • Methoxy-X04

    Methoxy-X04, a derivative of Congo red and Chrysamine-G, is a brain-permeable fluorescent probe for amyloid-β (Aβ).

  • Didymin

    Didymin has antioxidant property. Didymin induces apoptosis by inhibiting N-Myc and upregulating RKIP in neuroblastoma, may used for neuroblastoma therapy.